Stoke Therapeutics Stock Price History
STOK Stock | USD 8.33 0.07 0.85% |
Below is the normalized historical share price chart for Stoke Therapeutics extending back to June 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Stoke Therapeutics stands at 8.33, as last reported on the 20th of March, with the highest price reaching 8.41 and the lowest price hitting 8.00 during the day.
If you're considering investing in Stoke Stock, it is important to understand the factors that can impact its price. Stoke Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0938, which indicates the firm had a -0.0938 % return per unit of risk over the last 3 months. Stoke Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stoke Therapeutics' Risk Adjusted Performance of (0.1), coefficient of variation of (827.00), and Variance of 22.25 to confirm the risk estimate we provide.
The value of Total Stockholder Equity is estimated to slide to about 193.3 M. The value of Common Stock Total Equity is estimated to slide to 2,750. At this time, Stoke Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 2.73 this year, although the value of Price To Operating Cash Flows Ratio will most likely fall to (7.20). Stoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of June 2019 | 200 Day MA 12.4643 | 50 Day MA 9.5086 | Beta 0.985 |
Stoke |
Sharpe Ratio = -0.0938
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | STOK |
Estimated Market Risk
4.77 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Stoke Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stoke Therapeutics by adding Stoke Therapeutics to a well-diversified portfolio.
Price Book 1.9504 | Enterprise Value Ebitda (3.62) | Price Sales 12.8523 | Shares Float 36.8 M | Wall Street Target Price 23.875 |
Stoke Therapeutics Stock Price History Chart
There are several ways to analyze Stoke Stock price data. The simplest method is using a basic Stoke candlestick price chart, which shows Stoke Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 6, 2025 | 12.74 |
Lowest Price | March 3, 2025 | 7.4 |
Stoke Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Stoke Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Stoke Stock. It can be used to describe the percentage change in the price of Stoke Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Stoke Stock.Stoke Therapeutics Accumulation Distribution | 52,193 | |
Stoke Therapeutics Price Daily Balance Of Power | 0.17 | |
Stoke Therapeutics Price Rate Of Daily Change | 1.01 | |
Stoke Therapeutics Price Action Indicator | 0.16 |
Stoke Therapeutics March 20, 2025 Stock Price Analysis
Stoke Stock Price History Data
The price series of Stoke Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 5.58 with a coefficient of variation of 15.21. The price distribution for the period has arithmetic mean of 10.02. The median price for the last 90 days is 10.26. The company completed stock split (1:9) on 6th of June 2019.Open | High | Low | Close | Volume | ||
03/20/2025 | 8.05 | 8.41 | 8.00 | 8.33 | 1,070,583 | |
03/19/2025 | 8.95 | 8.95 | 8.03 | 8.26 | 1,260,607 | |
03/18/2025 | 8.63 | 8.93 | 7.71 | 8.87 | 1,628,628 | |
03/17/2025 | 8.60 | 9.04 | 8.50 | 9.00 | 822,458 | |
03/14/2025 | 8.18 | 8.72 | 8.18 | 8.60 | 876,916 | |
03/13/2025 | 8.44 | 8.61 | 8.10 | 8.11 | 535,770 | |
03/12/2025 | 8.25 | 8.59 | 8.13 | 8.52 | 516,170 | |
03/11/2025 | 7.96 | 8.28 | 7.65 | 8.20 | 500,959 | |
03/10/2025 | 7.96 | 8.20 | 7.70 | 7.95 | 724,109 | |
03/07/2025 | 8.07 | 8.21 | 7.82 | 8.01 | 513,059 | |
03/06/2025 | 8.01 | 8.19 | 7.91 | 8.15 | 422,308 | |
03/05/2025 | 7.51 | 8.20 | 7.51 | 8.16 | 627,897 | |
03/04/2025 | 7.34 | 7.69 | 7.22 | 7.58 | 585,483 | |
03/03/2025 | 7.84 | 7.93 | 7.31 | 7.40 | 710,872 | |
02/28/2025 | 7.98 | 8.13 | 7.77 | 7.85 | 691,626 | |
02/27/2025 | 8.32 | 8.52 | 7.99 | 7.99 | 442,631 | |
02/26/2025 | 8.25 | 8.37 | 8.13 | 8.27 | 523,567 | |
02/25/2025 | 8.46 | 8.63 | 8.24 | 8.25 | 671,615 | |
02/24/2025 | 8.33 | 8.74 | 8.13 | 8.50 | 891,253 | |
02/21/2025 | 8.90 | 9.14 | 8.20 | 8.33 | 1,044,167 | |
02/20/2025 | 9.30 | 9.33 | 8.49 | 8.74 | 1,664,256 | |
02/19/2025 | 9.80 | 9.94 | 9.20 | 9.30 | 1,054,804 | |
02/18/2025 | 10.80 | 11.11 | 9.69 | 9.71 | 1,630,273 | |
02/14/2025 | 10.70 | 11.07 | 10.58 | 10.68 | 365,803 | |
02/13/2025 | 10.43 | 10.64 | 10.00 | 10.63 | 729,617 | |
02/12/2025 | 10.03 | 10.35 | 9.94 | 10.26 | 596,073 | |
02/11/2025 | 10.04 | 10.36 | 9.76 | 10.32 | 347,399 | |
02/10/2025 | 11.13 | 11.46 | 9.98 | 10.27 | 1,004,768 | |
02/07/2025 | 12.74 | 12.90 | 11.28 | 11.35 | 641,268 | |
02/06/2025 | 12.78 | 12.82 | 12.46 | 12.74 | 701,873 | |
02/05/2025 | 12.69 | 12.98 | 12.50 | 12.70 | 1,022,066 | |
02/04/2025 | 11.52 | 12.85 | 11.30 | 12.60 | 1,375,421 | |
02/03/2025 | 11.15 | 11.81 | 11.03 | 11.52 | 1,028,992 | |
01/31/2025 | 11.07 | 11.73 | 10.92 | 11.48 | 898,881 | |
01/30/2025 | 10.66 | 11.15 | 10.55 | 10.99 | 525,797 | |
01/29/2025 | 9.80 | 10.85 | 9.76 | 10.51 | 726,098 | |
01/28/2025 | 10.50 | 10.60 | 9.72 | 9.82 | 473,422 | |
01/27/2025 | 10.53 | 11.11 | 10.36 | 10.57 | 418,501 | |
01/24/2025 | 10.59 | 10.85 | 10.48 | 10.62 | 351,177 | |
01/23/2025 | 9.90 | 10.67 | 9.66 | 10.60 | 663,567 | |
01/22/2025 | 9.77 | 10.43 | 9.66 | 10.02 | 687,130 | |
01/21/2025 | 9.47 | 9.82 | 9.30 | 9.80 | 837,640 | |
01/17/2025 | 9.55 | 9.65 | 9.35 | 9.36 | 272,475 | |
01/16/2025 | 9.59 | 9.59 | 8.98 | 9.46 | 745,990 | |
01/15/2025 | 9.04 | 9.77 | 8.81 | 9.49 | 1,405,160 | |
01/14/2025 | 9.00 | 9.14 | 8.42 | 8.68 | 916,883 | |
01/13/2025 | 8.89 | 9.00 | 8.55 | 8.92 | 1,454,008 | |
01/10/2025 | 9.00 | 9.11 | 8.77 | 9.00 | 1,612,679 | |
01/08/2025 | 9.54 | 9.54 | 8.76 | 8.96 | 1,037,383 | |
01/07/2025 | 9.82 | 10.56 | 8.88 | 9.31 | 2,308,942 | |
01/06/2025 | 11.51 | 11.63 | 10.98 | 11.02 | 528,683 | |
01/03/2025 | 11.18 | 11.73 | 11.18 | 11.49 | 682,057 | |
01/02/2025 | 11.13 | 11.68 | 10.99 | 11.27 | 403,374 | |
12/31/2024 | 10.96 | 11.09 | 10.77 | 11.03 | 206,963 | |
12/30/2024 | 10.86 | 11.09 | 10.53 | 10.80 | 510,345 | |
12/27/2024 | 11.12 | 11.54 | 10.91 | 11.06 | 324,304 | |
12/26/2024 | 11.22 | 11.47 | 11.02 | 11.24 | 439,995 | |
12/24/2024 | 11.35 | 11.61 | 11.10 | 11.32 | 517,326 | |
12/23/2024 | 11.58 | 11.79 | 11.35 | 11.61 | 2,552,306 | |
12/20/2024 | 10.81 | 11.84 | 10.81 | 11.68 | 1,183,080 | |
12/19/2024 | 11.21 | 11.34 | 10.61 | 11.30 | 769,008 |
About Stoke Therapeutics Stock history
Stoke Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Stoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Stoke Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Stoke Therapeutics stock prices may prove useful in developing a viable investing in Stoke Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 54 M | 35.9 M | |
Net Loss | -91 M | -86.4 M |
Stoke Therapeutics Quarterly Net Working Capital |
|
Stoke Therapeutics Stock Technical Analysis
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Stoke Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Stoke Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Stoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Stoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.1) | |||
Jensen Alpha | (0.46) | |||
Total Risk Alpha | (0.18) | |||
Treynor Ratio | (0.37) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share | Quarterly Revenue Growth 7.071 | Return On Assets | Return On Equity |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.